Skip to content

GENTEX CORPORATION: 10-K filed 2026-02-24

What GENTEX CORPORATION reported in its annual report filed 2026-02-24 (fiscal FY 2025): 55 published measures, 145 facts as tagged in accession 0000355811-26-000010.

This filing

Form
10-K (annual report)
Filed
2026-02-24
Fiscal period
fiscal FY 2025
Accession
0000355811-26-000010 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENTEX CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-12-312,928,592,834USD
At 2024-12-312,760,820,975USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-12-31437,660,897USD
At 2024-12-31288,721,320USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-12-312,487,829,724USD
At 2024-12-312,467,950,655USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-12-31145,645,715USD
At 2024-12-31233,318,766USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-12-31384,841,367USD365
2024-01-01 to 2024-12-31404,487,743USD366
2023-01-01 to 2023-12-31428,403,272USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-12-31587,126,291USD365
2024-01-01 to 2024-12-31498,213,220USD366
2023-01-01 to 2023-12-31537,249,592USD365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-01-01 to 2025-12-312,534,268,965USD365
2024-01-01 to 2024-12-312,313,314,333USD366
2023-01-01 to 2023-12-312,299,215,044USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-407,899,821USD365
2024-01-01 to 2024-12-31-289,251,056USD366
2023-01-01 to 2023-12-31-230,152,891USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-266,899,521USD365
2024-01-01 to 2024-12-31-202,078,417USD366
2023-01-01 to 2023-12-31-299,416,320USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-12-311,466,046,002USD
At 2024-12-311,450,287,128USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-01-01 to 2025-12-31217,834,174shares365
2024-01-01 to 2024-12-31225,710,698shares366
2023-01-01 to 2023-12-31229,405,479shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-12-31217,848,653shares365
2024-01-01 to 2024-12-31226,023,482shares366
2023-01-01 to 2023-12-31229,720,198shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-01-01 to 2025-12-311.74USD/shares365
2024-01-01 to 2024-12-311.77USD/shares366
2023-01-01 to 2023-12-311.84USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-12-311.74USD/shares365
2024-01-01 to 2024-12-311.76USD/shares366
2023-01-01 to 2023-12-311.84USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-01-01 to 2025-12-3176,380,338USD365
2024-01-01 to 2024-12-3167,725,940USD366
2023-01-01 to 2023-12-3176,577,902USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-12-31790,935,378USD
At 2024-12-31728,481,467USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-12-3136,649,818USD365
2024-01-01 to 2024-12-3139,539,362USD366
2023-01-01 to 2023-12-3139,197,422USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-31473,935,754USD365
2024-01-01 to 2024-12-31459,726,573USD366
2023-01-01 to 2023-12-31495,731,053USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-12-311,128,434,468USD
At 2024-12-311,037,328,170USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-12-31387,542,969USD
At 2024-12-31252,692,676USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-12-31248,983,498USD
At 2024-12-31168,314,912USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-12-31357,211,919USD
At 2024-12-31340,668,927USD
At 2023-12-31340,105,631USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-12-31368,517,569USD
At 2024-12-31295,344,353USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2025-01-01 to 2025-12-31315,499,459USD365
2024-01-01 to 2024-12-31206,108,138USD366
2023-01-01 to 2023-12-31147,401,103USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-12-31392,773,186USD365
2024-01-01 to 2024-12-31311,363,617USD366
2023-01-01 to 2023-12-31266,898,955USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-12-31516,253,617USD
At 2024-12-31436,497,445USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-12-31866,708,940USD365
2024-01-01 to 2024-12-31771,090,190USD366
2023-01-01 to 2023-12-31762,630,008USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-01-01 to 2025-12-31177,868,692USD365
2024-01-01 to 2024-12-31121,023,692USD366
2023-01-01 to 2023-12-31112,539,255USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-01-01 to 2025-12-31203,259,756USD365
2024-01-01 to 2024-12-31181,475,221USD366
2023-01-01 to 2023-12-31154,359,700USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-12-31215,445,024shares
At 2024-12-31227,207,472shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-12-31145,645,715USD
At 2024-12-31233,318,766USD
At 2023-12-31226,435,019USD
At 2022-12-31218,754,638USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-12-312,487,829,724USD
At 2024-12-312,472,099,655USD
At 2023-12-312,312,517,069USD
At 2022-12-312,065,792,821USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-12-318,728,535USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-12-311,914,749,170USD
At 2024-12-311,774,278,097USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-12-311,123,813,792USD
At 2024-12-311,045,796,630USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-12-31189,341,387USD
At 2024-12-31195,157,160USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-12-311,009,222,988USD
At 2024-12-31995,011,338USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-12-3149,209,006USD
At 2024-12-3136,028,644USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-12-3192,631,001USD
At 2024-12-3149,862,777USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-12-31189,907,395USD
At 2024-12-31126,027,367USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2025-12-31908,922USD
At 2024-12-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-12-31461,062,415USD365
2024-01-01 to 2024-12-31472,213,683USD366
2023-01-01 to 2023-12-31504,981,174USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-12-31384,682,077USD365
2024-01-01 to 2024-12-31404,487,743USD366
2023-01-01 to 2023-12-31428,403,272USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-01-01 to 2025-12-31391,518,462USD365
2024-01-01 to 2024-12-31404,635,524USD366
2023-01-01 to 2023-12-31435,989,084USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-12-3188,800,000USD365
2024-01-01 to 2024-12-3176,800,000USD366
2023-01-01 to 2023-12-3173,600,000USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-12-31104,041,764USD365
2024-01-01 to 2024-12-3194,714,662USD366
2023-01-01 to 2023-12-3193,321,192USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-11,584,089USD365
2024-01-01 to 2024-12-31-915,731USD366
2023-01-01 to 2023-12-31-4,248,230USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-12,873,339USD365
2024-01-01 to 2024-12-3112,487,110USD366
2023-01-01 to 2023-12-319,250,121USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2025-01-01 to 2025-12-3194,786,584USD365
2024-01-01 to 2024-12-3180,147,352USD366
2023-01-01 to 2023-12-3194,313,012USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-18,406,246USD365
2024-01-01 to 2024-12-31-12,421,412USD366
2023-01-01 to 2023-12-31-17,735,110USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-01-01 to 2025-12-3178,699,665USD365
2024-01-01 to 2024-12-3186,200,000USD366
2023-01-01 to 2023-12-31110,300,000USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-12-3114,460,201USD365
2024-01-01 to 2024-12-3127,295,127USD366
2023-01-01 to 2023-12-3129,398,272USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-3114,615,535USD365
2024-01-01 to 2024-12-31-27,106,680USD366
2023-01-01 to 2023-12-3145,251,116USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-18,138,298USD365
2024-01-01 to 2024-12-3132,624,417USD366
2023-01-01 to 2023-12-31-2,127,242USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-3152,402,600USD365
2024-01-01 to 2024-12-31-26,021,165USD366
2023-01-01 to 2023-12-3140,951,490USD365

Inspect the source

Entity
GENTEX CORPORATION / CIK 0000355811
Captured
2026-09-19T14:57:30.647Z
SEC response SHA-256
eb99451c516d46096834feea4e32d587225b1e40e8c07b7e0c0a0961878fc624

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000355811.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))